Gyros PTi Webinar
Assessing the immunogenicity of biopharmaceuticals
Immunogenicity of therapeutic biopharmaceuticals can impact both the efficacy and the safety of the product. Assessment of anti-drug antibodies (ADAs) as well as neutralizing antibodies (NAbs) is a fundamental part of immunogenicity testing.
By attending this webinar, you will learn:
- how the Gyrolab™ platform automates drug-tolerant ADA immunoassays in a time-efficient way using small volumes of patient samples and reagents
- how iLite® Assay Ready reporter gene cell lines are designed to overcome limitations of conventional cell-based assays in the assessment of neutralizing antibodies
Speakers:
Cecilia Bill, Application Scientist, Gyros Protein Technologies AB
Frida Pauly, Manager Biopharma Solutions,Euro Diagnostica AB
Cecilia and Frida will answer your questions live during the broadcast!
Date: Thursday, November 9, 2017
Time: 10:00 AM Central European Time, (4:00 AM EST, 1:00 AM PST)
6:00 PM Central European Time, 12:00 PM EST, 9:00 AM PST
Contact Benjamin at benjamin@hobsonsinstruments.com.au if you would like to participate.
Gyrolab is a trademark of Gyros Protein Technologies Group. iLite is a registered trademark of Euro Diagnostica.